MedTrace Logo

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

NCT06211868 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-10-15

No results posted yet for this study

Summary

Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.

Conditions

Interventions

BEHAVIORAL

Digital wearable and AI-human symbiotic lifestyle intervention

Digital wearable and AI-human symbiotic lifestyle intervention

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2029-09-01
Completion
2030-09-01

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06211868 on ClinicalTrials.gov